Sandra L Helmers

Summary

Affiliation: Emory University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study
    S L Helmers
    Department of Neurology, Division of Epilepsy and Clinical Neurophysiology, Children s Hospital, Boston, MA, USA
    J Child Neurol 16:843-8. 2001
  2. ncbi request reprint Observations on the use of vagus nerve stimulation earlier in the course of pharmacoresistant epilepsy: patients with seizures for six years or less
    Sandra L Helmers
    Emory University School of Medicine, Atlanta, GA, USA
    Neurologist 9:160-4. 2003
  3. doi request reprint Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy
    Sandra L Helmers
    Emory University School of Medicine, Atlanta, GA 30322, United States
    Eur J Paediatr Neurol 16:449-58. 2012
  4. doi request reprint Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy
    Sandra L Helmers
    Emory University School of Medicine, Atlanta, GA 30322, USA
    Epilepsy Behav 22:370-5. 2011
  5. doi request reprint Economic burden associated with the use of generic antiepileptic drugs in the United States
    Sandra L Helmers
    Department of Neurology, Emory University, Atlanta, GA, USA
    Epilepsy Behav 18:437-44. 2010
  6. ncbi request reprint Hormonal consequences of epilepsy
    Adenike Opaleke
    Emory Comprehensive Epilepsy Program, Emory University School of Medicine, The Emory Clinic, Atlanta, GA 30322, USA
    Semin Pediatr Neurol 14:189-95. 2007
  7. doi request reprint Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort
    Leslie J Cloud
    Department of Neurology, Virginia Commonwealth University, Richmond, Virginia 23298 0539, USA
    Mov Disord 27:1797-800. 2012
  8. ncbi request reprint The new antiepileptic drugs: clinical applications
    Suzette M LaRoche
    Department of Neurology, Emory University, Atlanta, GA, USA
    JAMA 291:615-20. 2004
  9. ncbi request reprint The new antiepileptic drugs: scientific review
    Suzette M LaRoche
    Department of Neurology, Emory University, Atlanta, GA, USA
    JAMA 291:605-14. 2004
  10. ncbi request reprint Epilepsy in the elderly
    Suzette M LaRoche
    Department of Neurology, Emory University, Altanta, GA 30322, USA
    Neurologist 9:241-9. 2003

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study
    S L Helmers
    Department of Neurology, Division of Epilepsy and Clinical Neurophysiology, Children s Hospital, Boston, MA, USA
    J Child Neurol 16:843-8. 2001
    ..We concluded that vagus nerve stimulation is an effective treatment for medically refractory epilepsy in children...
  2. ncbi request reprint Observations on the use of vagus nerve stimulation earlier in the course of pharmacoresistant epilepsy: patients with seizures for six years or less
    Sandra L Helmers
    Emory University School of Medicine, Atlanta, GA, USA
    Neurologist 9:160-4. 2003
    ..Patients in the study had pharmacoresistant seizures for 6 years or less (early treatment group) or more than 6 years (late treatment group) before initiation of VNS therapy, and results are provided after both 3 and 12 months...
  3. doi request reprint Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy
    Sandra L Helmers
    Emory University School of Medicine, Atlanta, GA 30322, United States
    Eur J Paediatr Neurol 16:449-58. 2012
    ..VNS (Vagus Nerve Stimulation Therapy) is approved in the USA to treat refractory epilepsy as adjunctive to antiepileptic drugs (AEDs) in patients ≥12 years with complex partial seizures...
  4. doi request reprint Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy
    Sandra L Helmers
    Emory University School of Medicine, Atlanta, GA 30322, USA
    Epilepsy Behav 22:370-5. 2011
    ..Average total health care costs were lower post-VNS than pre-VNS ($18,550 vs $19,945 quarterly, P<0.001). VNS is associated with decreased resource utilization and epilepsy-related clinical events and net cost savings after 1.5 years...
  5. doi request reprint Economic burden associated with the use of generic antiepileptic drugs in the United States
    Sandra L Helmers
    Department of Neurology, Emory University, Atlanta, GA, USA
    Epilepsy Behav 18:437-44. 2010
    ..Significantly higher health care costs were observed during generic AED use across seizure control and AED subgroups...
  6. ncbi request reprint Hormonal consequences of epilepsy
    Adenike Opaleke
    Emory Comprehensive Epilepsy Program, Emory University School of Medicine, The Emory Clinic, Atlanta, GA 30322, USA
    Semin Pediatr Neurol 14:189-95. 2007
    ..We review effects of hormones on epilepsy and vice versa along with the effects of treatment (AEDs) on hormones in children...
  7. doi request reprint Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort
    Leslie J Cloud
    Department of Neurology, Virginia Commonwealth University, Richmond, Virginia 23298 0539, USA
    Mov Disord 27:1797-800. 2012
    ..Our ability to draw firm conclusions about defining EEG characteristics and response to AEDs was limited by the retrospective nature of the study. Future prospective studies are required...
  8. ncbi request reprint The new antiepileptic drugs: clinical applications
    Suzette M LaRoche
    Department of Neurology, Emory University, Atlanta, GA, USA
    JAMA 291:615-20. 2004
    ..This article aims to familiarize the general practitioner with the appropriate roles and effective uses of the new antiepileptic drugs in specific clinical scenarios...
  9. ncbi request reprint The new antiepileptic drugs: scientific review
    Suzette M LaRoche
    Department of Neurology, Emory University, Atlanta, GA, USA
    JAMA 291:605-14. 2004
    ..Primary care physicians often care for patients with epilepsy and therefore should be familiar with the new options available...
  10. ncbi request reprint Epilepsy in the elderly
    Suzette M LaRoche
    Department of Neurology, Emory University, Altanta, GA 30322, USA
    Neurologist 9:241-9. 2003
    ..Epilepsy is one of the most common neurologic diseases that affect the elderly population. Underlying etiologies as well as diagnostic and treatment issues vary from that of younger adults and deserve special consideration...
  11. ncbi request reprint Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use
    Christi Heck
    USC Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Neurology 59:S31-7. 2002
    ..Finally, we provide an algorithm for the adjustment of VNS device settings (see Appendices)...
  12. ncbi request reprint An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability
    Arthur J Barela
    Department of Microbiology and Molecular Genetics, University of California, Irvine, California 92697 4025, USA
    J Neurosci 26:2714-23. 2006
    ..Therefore, this mutation should lead to decreased neuronal excitability, in contrast to most previous GEFS+ sodium channel mutations, which have changes predicted to increase neuronal firing...